Beam Therapeutics Inc. (BMV:BEAM)

Beam Therapeutics Ratios and Metrics

Market cap in millions MXN. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 8, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Cap	47,971	38,568	41,319	51,836	101,341	86,917
Market Cap Growth	26.31%	-6.66%	-20.29%	-48.85%	16.60%	-
Enterprise Value	29,508	25,499	22,166	34,924	85,990	83,268
PE Ratio	-	-5.41	-15.83	-9.47	-13.81	-19.48
PS Ratio	42.20	32.65	5.88	45.76	105.12	194759.63
PB Ratio	2.43	2.83	2.26	3.80	6.59	19.03
P/TBV Ratio	41.91	2.78	2.14	3.73	6.19	15.54
P/FCF Ratio	-	-5.82	-12.15	-105.50	-48.20	-41.70
P/OCF Ratio	-	-5.97	-14.89	123.75	-82.24	-48.82
EV/Sales Ratio	26.40	21.59	3.16	30.83	89.20	186582.75
EV/EBITDA Ratio	-	-3.57	-8.11	-5.95	-12.01	-34.98
EV/EBIT Ratio	-	-3.30	-6.75	-5.55	-11.78	-33.73
EV/FCF Ratio	-4.40	-3.85	-6.52	-71.08	-40.90	-39.95
Debt / Equity Ratio	0.14	0.20	0.16	0.23	0.17	0.42
Debt / EBITDA Ratio	-0.36	-0.42	-1.17	-0.57	-0.38	-0.84
Debt / FCF Ratio	-0.43	-0.45	-0.94	-6.77	-1.31	-0.96
Asset Turnover	0.05	0.05	0.27	0.04	0.05	0.00
Quick Ratio	6.61	4.67	5.79	4.82	5.93	2.93
Current Ratio	6.75	4.82	5.89	4.89	5.96	3.01
Return on Equity (ROE)	-44.78%	-43.94%	-15.46%	-37.06%	-69.13%	-875.42%
Return on Assets (ROA)	-35.75%	-32.42%	-12.73%	-24.35%	-40.75%	-43.69%
Return on Capital (ROIC)	-128.38%	-119.20%	-47.27%	-80.96%	-119.91%	-89.73%
Return on Capital Employed (ROCE)	-41.70%	-38.20%	-14.88%	-28.45%	-48.74%	-55.75%
Earnings Yield	-15.67%	-18.47%	-6.32%	-10.56%	-7.24%	-5.13%
FCF Yield	-13.98%	-17.17%	-8.23%	-0.95%	-2.07%	-2.40%
Buyback Yield / Dilution	-0.36%	-0.40%	-12.57%	-4.09%	-14.07%	-6.90%
Total Shareholder Return	-	-0.40%	-12.57%	-4.09%	-14.07%	-6.90%

Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.